• Increase font size
  • Default font size
  • Decrease font size

BioElectronics Receives Groundbreaking Patent

Print E-mail
By Jamie Tera & Wire Reports   
Thursday, 25 June 2009 13:21
BioElectronics Corp. (OTC: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the United States Patent and Trademark Office has issued a significant new patent to the Company. The patent protects BioElectronics Corp's systems and techniques for applying an electromagnetic field to bodily tissue including a self-contained and portable electromagnetic field generating device disposed over a surface of bodily tissue. PEMF technology has been proven safe and effective in hundreds of peer-reviewed scientific studies. Up until now, however, PEMF devices have been very expensive large devices and usually based in clinical settings such as clinics or hospitals. Through the use of advanced micro-circuitry the engineers at BioElectronics have shrunk this technology into a wafer-thin device that can be worn directly on the skin to relieve pain, swelling and speed healing.

"This is a very important and significant event for BioElectronics. As consumers and the U.S. Food and Drug Administration become increasingly aware of the potential dangers of drugs such as acetaminophen, consumers are increasingly searching for alternatives," commented Andrew Whelan, CEO of BioElectronics. "PEMF therapy is a proven safe and effective alternative for many musculoskeletal disorders and there is a growing body of research showing its effectiveness in speeding surgical recovery and in reducing, or completely eliminating, the amount of pain medication required. This patent ensures our ability to be the sole provider of this technology in a wearable and portable form factor and significantly increases the value of our Company."

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (http://www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 2 hours ago A Stem-Cell-Based Drug Gets Approval in Canada $OSIR http://t.co/XI3gAfMY
about 3 hours ago $JNJ Zytiga, a Prostate Cancer Drug, Does Well in Trial http://t.co/v7YUm9b6
about 4 hours ago $PFE Pfizer Lung Drug Stops Deadly Child Cancers in Study | http://t.co/hcfdrnCY
about 5 hours ago Human Genome Looks to Anyone but GlaxoSmithKline | http://t.co/d4IMkIn3
about 6 hours ago When David Einhorn did not mention Herbalife $HLF as a potential short candidate, that stock shot up on Wednesday | http://t.co/XpFKihQS
about 7 hours ago Stock Market: Stocks Get Hammered On Disappointing Data, Greece Worries http://t.co/FyH8zpru
about 7 hours ago Synergy Pharmaceuticals (SGYP) May Be Ready To Roll - Small Cap Stock Market Investing Tips http://t.co/FHYXlF1Q
about 10 hours ago Alvine Presents Results from Phase 2A Trial of ALV003 in Celiac Disease Patients -2012 Digestive Diseases Week Meeting http://t.co/e6Rjhbj9

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified